Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Evaluation of polyamines as marker of melanoma cell proliferation and differentiation by an improved high-performance liquid chromatographic method.

Provenzano B, Lentini A, Tatti R, De Martino A, Borromeo I, Mischiati C, Feriotto G, Forni C, Tabolacci C, Beninati S.

Amino Acids. 2019 Oct 15. doi: 10.1007/s00726-019-02799-y. [Epub ahead of print]

PMID:
31617109
2.

The Role of Tissue Transglutaminase in Cancer Cell Initiation, Survival and Progression.

Tabolacci C, De Martino A, Mischiati C, Feriotto G, Beninati S.

Med Sci (Basel). 2019 Jan 25;7(2). pii: E19. doi: 10.3390/medsci7020019. Review.

3.

Antiproliferative activity of novel isatinyl/indanyl nitrones (INs) as potential spin trapping agents of free radical intermediates.

Maiuolo L, Feriotto G, Algieri V, Nardi M, Russo B, Di Gioia ML, Furia E, Tallarida MA, Mischiati C, De Nino A.

Medchemcomm. 2017 Dec 20;9(2):299-304. doi: 10.1039/c7md00537g. eCollection 2018 Feb 1.

4.

Selected terpenes from leaves of Ocimum basilicum L. induce hemoglobin accumulation in human K562 cells.

Feriotto G, Marchetti N, Costa V, Torricelli P, Beninati S, Tagliati F, Mischiati C.

Fitoterapia. 2018 Jun;127:173-178. doi: 10.1016/j.fitote.2018.02.016. Epub 2018 Feb 13.

PMID:
29447985
5.

Chemical Composition of Essential Oils from Thymus vulgaris, Cymbopogon citratus, and Rosmarinus officinalis, and Their Effects on the HIV-1 Tat Protein Function.

Feriotto G, Marchetti N, Costa V, Beninati S, Tagliati F, Mischiati C.

Chem Biodivers. 2018 Feb;15(2). doi: 10.1002/cbdv.201700436. Epub 2018 Jan 31.

PMID:
29282856
6.

Involvement of cell surface TG2 in the aggregation of K562 cells triggered by gluten.

Feriotto G, Calza R, Bergamini CM, Griffin M, Wang Z, Beninati S, Ferretti V, Marzola E, Guerrini R, Pagnoni A, Cavazzini A, Casciano F, Mischiati C.

Amino Acids. 2017 Mar;49(3):551-565. doi: 10.1007/s00726-016-2339-4. Epub 2016 Oct 3.

PMID:
27699491
7.

A novel hybrid drug between two potent anti-tubulin agents as a potential prolonged anticancer approach.

Marchetti P, Pavan B, Simoni D, Baruchello R, Rondanin R, Mischiati C, Feriotto G, Ferraro L, Hsu LC, Lee RM, Dalpiaz A.

Eur J Pharm Sci. 2016 Aug 25;91:50-63. doi: 10.1016/j.ejps.2016.05.032. Epub 2016 Jun 1.

PMID:
27262542
8.

Potential role of circulating microRNAs as early markers of preeclampsia.

Ura B, Feriotto G, Monasta L, Bilel S, Zweyer M, Celeghini C.

Taiwan J Obstet Gynecol. 2014 Jun;53(2):232-4. doi: 10.1016/j.tjog.2014.03.001.

9.

Comparative proteomic analysis of ductal breast carcinoma demonstrates an altered expression of chaperonins and cytoskeletal proteins.

Carcoforo P, Ura B, Mischiati C, Squerzanti M, Lanzara V, Cervellati C, Calza R, De Laureto PP, Frare E, Portinari M, Feriotto G, Lanzara S, Agostinelli E, Bergamini CM.

Mol Med Rep. 2013 May;7(5):1700-4. doi: 10.3892/mmr.2013.1375. Epub 2013 Mar 15.

PMID:
23525150
10.

Production of beta-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous beta(0)39 thalassemia patients.

Salvatori F, Breveglieri G, Zuccato C, Finotti A, Bianchi N, Borgatti M, Feriotto G, Destro F, Canella A, Brognara E, Lampronti I, Breda L, Rivella S, Gambari R.

Am J Hematol. 2009 Nov;84(11):720-8. doi: 10.1002/ajh.21539.

11.

Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs.

Lampronti I, Bianchi N, Zuccato C, Dall'Acqua F, Vedaldi D, Viola G, Potenza R, Chiavilli F, Breveglieri G, Borgatti M, Finotti A, Feriotto G, Salvatori F, Gambari R.

Int J Hematol. 2009 Oct;90(3):318-327. doi: 10.1007/s12185-009-0422-2. Epub 2009 Sep 25.

PMID:
19777196
12.

Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassaemia mutation for the screening of correctors of stop-codon mutations.

Salvatori F, Cantale V, Breveglieri G, Zuccato C, Finotti A, Bianchi N, Borgatti M, Feriotto G, Destro F, Canella A, Breda L, Rivella S, Gambari R.

Biotechnol Appl Biochem. 2009 Jul 9;54(1):41-52. doi: 10.1042/BA20080266.

13.

Upstream stimulatory factors are involved in the P1 promoter directed transcription of the A beta H-J-J locus.

Finotti A, Treves S, Zorzato F, Gambari R, Feriotto G.

BMC Mol Biol. 2008 Dec 16;9:110. doi: 10.1186/1471-2199-9-110.

14.

A novel frameshift mutation (+A) at codon 18 of the beta-globin gene associated with high persistence of fetal hemoglobin phenotype and deltabeta-thalassemia.

Feriotto G, Salvatori F, Finotti A, Breveglieri G, Venturi M, Zuccato C, Bianchi N, Borgatti M, Lampronti I, Mancini I, Massei F, Favre C, Gambari R.

Acta Haematol. 2008;119(1):28-37. doi: 10.1159/000114204. Epub 2008 Jan 30.

PMID:
18230963
15.
16.

Transcriptional activity and Sp 1/3 transcription factor binding to the P1 promoter sequences of the human AbetaH-J-J locus.

Feriotto G, Finotti A, Breveglieri G, Treves S, Zorzato F, Gambari R.

FEBS J. 2007 Sep;274(17):4476-90. Epub 2007 Aug 6.

17.

Multiple levels of control of the expression of the human A beta H-J-J locus encoding aspartyl-beta-hydroxylase, junctin, and junctate.

Feriotto G, Finotti A, Breveglieri G, Treves S, Zorzato F, Gambari R.

Ann N Y Acad Sci. 2006 Dec;1091:184-90. Review.

PMID:
17341613
18.

Surface plasmon resonance for detection of genetically modified organisms in the food supply.

Gambari R, Feriotto G.

J AOAC Int. 2006 May-Jun;89(3):893-7. Review.

PMID:
16792091
19.

Modular usage of the HLA-DRA promoter in extra-hematopoietic and hematopoietic cell types of transgenic mice.

Giorda E, Sibilio L, Martayan A, Feriotto G, Bianchi N, Mischiati C, Di Rosa F, Pozzi L, Gambari R, Giacomini P.

FEBS J. 2005 Jun;272(12):3214-26.

20.

Separation of white blood cells from erythrocytes on a dielectrophoresis (DEP) based 'Lab-on-a-chip' device.

Borgatti M, Altomare L, Baruffa M, Fabbri E, Breveglieri G, Feriotto G, Manaresi N, Medoro G, Romani A, Tartagni M, Gambari R, Guerrieri R.

Int J Mol Med. 2005 Jun;15(6):913-20.

PMID:
15870893
21.

Myocyte enhancer factor 2 activates promoter sequences of the human AbetaH-J-J locus, encoding aspartyl-beta-hydroxylase, junctin, and junctate.

Feriotto G, Finotti A, Volpe P, Treves S, Ferrari S, Angelelli C, Zorzato F, Gambari R.

Mol Cell Biol. 2005 Apr;25(8):3261-75.

22.

Surface plasmon resonance and biosensor technology for real-time molecular diagnosis of beta o 39 thalassemia mutation.

Feriotto G, Breveglieri G, Gardenghi S, Carandina G, Gambari R.

Mol Diagn. 2004;8(1):33-41.

PMID:
15230640
23.

Real-time multiplex analysis of four beta-thalassemia mutations employing surface plasmon resonance and biosensor technology.

Feriotto G, Breveglieri G, Finotti A, Gardenghi S, Gambari R.

Lab Invest. 2004 Jun;84(6):796-803.

24.

Binding of hybrid molecules containing pyrrolo [2,1-c][1,4]benzodiazepine (PBD) and oligopyrrole carriers to the human immunodeficiency type 1 virus TAR-RNA.

Mischiati C, Finotti A, Sereni A, Boschetti S, Baraldi PG, Romagnoli R, Feriotto G, Jeang KT, Bianchi N, Borgatti M, Gambari R.

Biochem Pharmacol. 2004 Feb 1;67(3):401-10.

PMID:
15037192
25.

Enhanced recognition of cystic fibrosis W1282X DNA point mutation by chiral peptide nucleic acid probes by a surface plasmon resonance biosensor.

Corradini R, Feriotto G, Sforza S, Marchelli R, Gambari R.

J Mol Recognit. 2004 Jan-Feb;17(1):76-84.

PMID:
14872540
26.
27.

Identification of a novel DNase I hypersensitive site within the far upstream region of the human HLA-DRA gene.

Tomassetti M, Feriotto G, Giacomini P, Giorda E, Bianchi N, Borgatti M, Finotti A, Mischiati C, Gambari R.

Int J Mol Med. 2003 Dec;12(6):929-34.

PMID:
14612968
28.

Inhibition of HIV-1 LTR-driven in vitro transcription by molecular hybrids based on peptide nucleic acids mimicking the NF-kappaB binding site.

Mischiati C, Borgatti M, Feriotto G, Rutigliano C, Breda L, Bianchi N, Gambari R.

Int J Mol Med. 2002 Jun;9(6):633-9.

PMID:
12011981
29.

Biosensor technology and surface plasmon resonance for real-time detection of genetically modified Roundup Ready soybean gene sequences.

Feriotto G, Borgatti M, Mischiati C, Bianchi N, Gambari R.

J Agric Food Chem. 2002 Feb 27;50(5):955-62.

PMID:
11853464
30.

Peptide nucleic acids and biosensor technology for real-time detection of the cystic fibrosis W1282X mutation by surface plasmon resonance.

Feriotto G, Corradini R, Sforza S, Bianchi N, Mischiati C, Marchelli R, Gambari R.

Lab Invest. 2001 Oct;81(10):1415-27.

31.

Aromatic polyamidines inhibiting the Tat-induced HIV-1 transcription recognize structured TAR-RNA.

Mischiati C, Jeang KT, Feriotto G, Breda L, Borgatti M, Bianchi N, Gambari R.

Antisense Nucleic Acid Drug Dev. 2001 Aug;11(4):209-17.

PMID:
11572598
32.

Biosensor technology for real-time detection of the cystic fibrosis W1282X mutation in CFTR.

Feriotto G, Ferlini A, Ravani A, Calzolari E, Mischiati C, Bianchi N, Gambari R.

Hum Mutat. 2001;18(1):70-81.

PMID:
11438995
33.

Computational procedures to explain the different biological activity of DNA/DNA, DNA/PNA and PNA/PNA hybrid molecules mimicking NF-kappaB binding sites.

Saviano M, Romanelli A, Bucci E, Pedone C, Mischiati C, Bianchi N, Feriotto G, Borgatti M, Gambari R.

J Biomol Struct Dyn. 2000 Dec;18(3):353-62.

PMID:
11149512
34.

[2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid inhibits DNA binding to transcription factor Sp1.

Baraldi PG, Cacciari B, Guiotto A, Romagnoli R, Spalluto G, Leoni A, Bianchi N, Feriotto G, Rutigliano C, Mischiati C, Gambari R.

Nucleosides Nucleotides Nucleic Acids. 2000 Aug;19(8):1219-29.

PMID:
11097052
37.

Liposomes as carriers for DNA-PNA hybrids.

Nastruzzi C, Cortesi R, Esposito E, Gambari R, Borgatti M, Bianchi N, Feriotto G, Mischiati C.

J Control Release. 2000 Aug 10;68(2):237-49.

PMID:
10925132
38.

Biospecific interaction analysis (BIA) of low-molecular weight DNA-binding drugs.

Gambari R, Feriotto G, Rutigliano C, Bianchi N, Mischiati C.

J Pharmacol Exp Ther. 2000 Jul;294(1):370-7.

PMID:
10871335
39.

Interaction of the human NF-kappaB p52 transcription factor with DNA-PNA hybrids mimicking the NF-kappaB binding sites of the human immunodeficiency virus type 1 promoter.

Mischiati C, Borgatti M, Bianchi N, Rutigliano C, Tomassetti M, Feriotto G, Gambari R.

J Biol Chem. 1999 Nov 12;274(46):33114-22.

40.

Analysis of the human HLA-DRA gene upstream region: evidence for a stem-loop array directed by nuclear factors.

Mischiati C, Feriotto G, Bianchi N, Rutigliano C, Giacomini P, Gambari R.

Biochimie. 1999 Mar;81(3):219-28.

PMID:
10385003
41.

Detection of the deltaF508 (F508del) mutation of the cystic fibrosis gene by surface plasmon resonance and biosensor technology.

Feriotto G, Lucci M, Bianchi N, Mischiati C, Gambari R.

Hum Mutat. 1999;13(5):390-400.

PMID:
10338094
42.

The DNA-binding drugs mithramycin and chromomycin are powerful inducers of erythroid differentiation of human K562 cells.

Bianchi N, Osti F, Rutigliano C, Corradini FG, Borsetti E, Tomassetti M, Mischiati C, Feriotto G, Gambari R.

Br J Haematol. 1999 Feb;104(2):258-65.

PMID:
10050705
44.

Biosensor technology and surface plasmon resonance for real-time detection of HIV-1 genomic sequences amplified by polymerase chain reaction.

Bianchi N, Rutigliano C, Tomassetti M, Feriotto G, Zorzato F, Gambari R.

Clin Diagn Virol. 1997 Nov;8(3):199-208.

PMID:
9406650
45.

Targeting of the HIV-1 long terminal repeat with chromomycin potentiates the inhibitory effects of a triplex-forming oligonucleotide on Sp1-DNA interactions and in vitro transcription.

Bianchi N, Rutigliano C, Passadore M, Tomassetti M, Pippo L, Mischiati C, Feriotto G, Gambari R.

Biochem J. 1997 Sep 15;326 ( Pt 3):919-27.

46.

Surface plasmon resonance for real-time detection of molecular interactions between chromomycin and target DNA sequences.

Gambari R, Bianchi N, Rutigliano C, Borsetti E, Tomassetti M, Feriotto G, Zorzato F.

Int J Oncol. 1997 Jul;11(1):145-9.

PMID:
21528193
47.

Conformation and surface expression of free HLA-CW1 heavy chains in the absence of beta 2-microglobulin.

Martayan A, Fiscella M, Setini A, Ciccarelli G, Gambari R, Feriotto G, Beretta A, Siccardi AG, Appella E, Giacomini P.

Hum Immunol. 1997 Mar;53(1):23-33.

PMID:
9127144
48.

In vitro and in vivo binding of a CC-1065 analogue to human gene sequences: a polymerase-chain reaction study.

Passadore M, Bianchi N, Feriotto G, Mischiati C, Rutigliano C, Gambari R.

Eur J Pharmacol. 1997 Jan 29;319(2-3):317-25.

PMID:
9042607
49.

Targeting of the Sp1 binding sites of HIV-1 long terminal repeat with chromomycin. Disruption of nuclear factor.DNA complexes and inhibition of in vitro transcription.

Bianchi N, Passadore M, Rutigliano C, Feriotto G, Mischiati C, Gambari R.

Biochem Pharmacol. 1996 Nov 22;52(10):1489-98.

PMID:
8937462
50.

Alteration of the expression of human estrogen receptor gene by distamycin.

Bianchi N, Passadore M, Feriotto G, Mischiati C, Gambari R, Piva R.

J Steroid Biochem Mol Biol. 1995 Sep;54(5-6):211-5.

PMID:
7577702

Supplemental Content

Loading ...
Support Center